Brewer's yeast cell wall affects microbiota composition and decreases Bacteroides fragilis populations in an anaerobic gut intestinal model

Journal of Bioscience and Bioengineering

Volumn 111, Issue 2, 2011, Pages 178-184

  Nakashimada, Yutaka ^a   Michinaka, Atsuko ^b   Watanabe, Kentaro ^a   Nishio, Naomichi ^a   Fujii, Toshio ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KIRIN HOLDINGS CO LTD   (Japan)

Author keywords

Biomass; In vitro culture system; Prebiotics; T RFLP; Yeast cell wall

Indexed keywords

BACTERIAL COMMUNITY; BACTEROIDES FRAGILIS; CONTINUOUS-FLOW REACTORS; HUMAN GUTS; IN-VITRO; LARGE INTESTINE; METABOLIC CHANGES; MICROBIOTAS; OPERATIONAL TAXONOMIC UNITS; PREBIOTICS; REACTOR SYSTEMS; T-RFLP; YEAST CELL; YEAST CELL WALL;

METABOLISM; POPULATION STATISTICS; WALLS (STRUCTURAL PARTITIONS); YEAST;

CELL CULTURE;

ACETIC ACID; BUTYRIC ACID; FORMIC ACID; LACTIC ACID; PROPIONIC ACID;

ANAEROBIC BACTERIUM; ANAEROBIC METABOLISM; ARTICLE; BACTEROIDES FRAGILIS; CARBOHYDRATE METABOLISM; CELL WALL; CONTINUOUS FLOW REACTOR SYSTEM; LACTOBACILLUS; LARGE INTESTINE; MEGASPHAELLA; MICROFLORA; NONHUMAN; SACCHAROMYCES CEREVISIAE; VEILLONELLA;

ANIMALS; BACTEROIDES FRAGILIS; CARBOHYDRATE METABOLISM; CELL WALL; DNA, BACTERIAL; FECES; FERMENTATION; INTESTINE, LARGE; LACTOBACILLUS; METAGENOME; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SACCHAROMYCES CEREVISIAE; SWINE;

BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS; LACTOBACILLUS; VEILLONELLA;

EID: 78951477258     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2010.09.005     Document Type: Article

References (51)

1. Duncan S.H., Scott K.P., Ramsay A.G., Harmsen H.J.M., Welling G.W., Stewart C.S., Flint H.J. Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system. Appl. Environ. Microbiol. 2003, 69:1136-1142.
2. Roberfroid M.B. Prebiotics: preferential substrates for specific germs?. Am. J. Clin. Nutr. 2001, 73:406S-409S.
3. Macfarlane G.T., Cummings J.H. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?. West. J. Med. 1999, 171:187-191.
4. Guslandi M., Giollo P., Testoni P.A. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 2003, 15:697-698.
5. Vilela E.G., Ferrari M.D.D., Torres H.O.D., Pinto A.G., Aguirre A.C.C., Martins F.P., Goulart E.M.A., Da Cunha A.S. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand. J. Gastroenterol. 2008, 43:842-848.
6. Zanello G., Meurens F., Berri M., Salmon H. Saccharomyces boulardii effects on gastrointestinal diseases. Curr. Issues Mol. Biol. 2008, 11:47-58.
7. Nakamura T., Agata K., Mizutani M., Iino H. Effects of Brewer's yeast cell wall on constipation and defecation in experimentally constipated rats. Biosci. Biotechnol. Biochem. 2001, 65:774-780.
8. Nakamura T., Nishida S., Mizutani M., Iino H. Effects of yogurt supplemented with brewer's yeast cell wall on constipation and intestinal microflora in rats. J. Nutr. Sci. Vitaminol. 2001, 47:367-372.
9. Hitomi Y., Yoshida M., Mizutani M., Nakamura T., Shimasaki H. Effects of brewer's yeast cell wall on fecal steroid excretion in rats. J. Oleo Sci. 2002, 51:335-346.
10. Nakamura T., Hitomi Y., Yoshida M., Shirasu Y., Tsukui T., Shimasaki H. Effect of yogurt supplemented with Brewer's Yeast Cell wall on levels of blood lipids in normal and hypercholesterolemic adults. J. Oleo Sci. 2002, 51:323-334.
11. Htwe K., Yee K.S., Tin M., Vandenplas Y. Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study. Am. J. Trop. Med. Hyg. 2008, 78:214-216.
12. Hitomi Y., Yoshida M., Nakamura T., Shirasu Y. Effects of brewer's yeast cell wall on serum lipid levels in rats fed a high cholesterol and fat diet. J. Oleo Sci. 2002, 51:141-144.
13. Jaehrig S.C., Rohn S., Kroh L.W., Fleischer L.G., Kurz T. In vitro potential antioxidant activity of (1->3), (1->6)-β -D-glucan and protein fractions from Saccharomyces cerevisiae Cell Walls. J. Agric. Food Chem. 2007, 55:4710-4716.
14. Macfarlane G.T., Macfarlane S., Gibson G.R. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb. Ecol. 1998, 35:180-187.
15. Degnan B.A., Macfarlane G.T. Carbohydrate utilization patterns and substrate preferences in Bacteroides thetaiotaomicron. Anaerobe 1995, 1:25-33.
16. Tzortzis G., Goulas A.K., Gee J.M., Gibson G.R. A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo. J. Nutr. 2005, 135:1726-1731.
17. Mäkeläinen H.S., Mäkivuokko H.A., Salminen S.J., Rautonen N.E., Ouwehand A.C. The effects of polydextrose and xylitol on microbial community and activity in a 4-stage colon simulator. J. Food Sci. 2007, 72:M153-M159.
18. De Boever P., Deplancke B., Verstraete W. Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder. J. Nutr. 2000, 130:2599-2606.
19. Inoue R., Tsukahara T., Nakanishi N., Ushida K. Development of the intestinal microbiota in the piglet. J. Gen. Appl. Microbiol. 2005, 51:257-265.
20. Hayashi H., Sakamoto M., Benno Y. Evaluation of three different forward primers by terminal restriction fragment length polymorphism analysis for determination of fecal Bifidobacterium spp. in healthy subjects. Microbiol. Immunol. 2004, 48:1-6.
21. Nishida S., Michinaka A., Nakashima K., Iino H., Fujii T. Evaluation of the probiotic potential of Lactobacillus paracasei KW3110 based on in vitro tests and oral administration tests in healthy adults. J. Gen. Appl. Microbiol. 2008, 54:267-276.
22. Cummings J.H., Pomare E.W., Branch W.J., Naylor C.P.E., Macfarlane G.T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987, 28:1221-1227.
23. Bourriaud C., Robins R.J., Martin L., Kozlowski F., Tenailleau E., Cherbut C., Michel C. Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident. J. Appl. Microbiol. 2005, 99:201-212.
24. Morrison D.J., Mackay W.G., Edwards C.A., Preston T., Dodson B., Weaver L.T. Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate?. Br. J. Nutr. 2006, 96:570-577.
25. Duncan S.H., Louis P., Flint H.J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 2004, 70:5810-5817.
26. Belenguer A., Duncan S.H., Holtrop G., Anderson S.E., Lobley G.E., Flint H.J. Impact of pH on lactate formation and utilization by human fecal microbial communities. Appl. Environ. Microbiol. 2007, 73:6526-6533.
27. Leser T.D., Amenuvor J.Z., Jensen T.K., Lindecrona R.H., Boye M., Moller K. Culture-independent analysis of gut bacteria: the pig gastrointestinal tract microbiota revisited. Appl. Environ. Microbiol. 2002, 68:673-690.
28. Cotta M.A., Whitehead T.R., Zeltwanger R.L. Isolation, characterization and comparison of bacteria from swine faeces and manure storage pits. Environ. Microbiol. 2003, 5:737-745.
29. Jackson M.S., Bird A.R., McOrist A.L. Comparison of two selective media for the detection and enumeration of Lactobacilli in human faeces. J. Microbiol. Meth. 2002, 51:313-321.
30. Matsuki T., Watanabe K., Fujimoto J., Miyamoto Y., Takada T., Matsumoto K., Oyaizu H., Tanaka R. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl. Environ. Microbiol. 2002, 68:5445-5451.
31. Matsuki T., Watanabe K., Fujimoto J., Takada T., Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl. Environ. Microbiol. 2004, 70:7220-7228.
32. Walker A.W., Duncan S.H., Leitch E.C.M., Child M.W., Flint H.J. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl. Environ. Microbiol. 2005, 71:3692-3700.
33. Ferris M.J., Masztal A., Aldridge K.E., Fortenberry D., Fidel P.L., Martin D.H. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect. Dis. 2004, 4:5.
34. Verhelst R., Verstraelen H., Claeys G., Verschraegen G., Delanghe J., Van Simaey L., De Ganck C., Temmerman M., Vaneechoutte M. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobiurn vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol. 2004, 4:16.
35. Burton J.P., Devillard E., Cadieux P.A., Hammond J.A., Reid G. Detection of Atopobium vaginae in postmenopausal worrien by cultivation-independent methods warrants further investigation. J. Clin. Microbiol. 2004, 42:1829-1831.
36. Saulnier D.M.A., Gibson G.R., Kolida S. In vitro effects of selected synbiotics on the human faecal microbiota composition. FEMS Microbiol. Ecol. 2008, 66:516-527.
37. Fukuda S., Ishikawa H., Koga Y., Aiba Y., Nakashima K., Cheng L., Shirakawa T. Allergic symptoms and microflora in schoolchildren. J. Adolesc. Health 2004, 35:156-158.
38. Odamaki T., Xiao J.-Z., Iwabuchi N., Sakamoto M., Takahashi N., Kondo S., Miyaji K., Iwatsuki K., Togashi H., Enomoto T., Benno Y. Influence of Bifidobacterium longum BB536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen season. J. Med. Microbiol. 2007, 56:1301-1308.
39. Vael C., Nelen V., Verhulst S., Goossens H., Desager K. Early intestinal Bacteroides fragilis colonisation and development of asthma. BMC Pulm. Med. 2008, 8:19.
40. Pathela P., Hasan K.Z., Roy E., Alam K., Huq F., Siddique A.K., Sack R.B. Enterotoxigenic Bacteroides fragilis associated diarrhea in children 0-2years of age in rural Bangladesh. J. Infect. Dis. 2005, 191:1245-1252.
41. Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chiang H.C., Hooper L.V., Gordon J.I. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003, 299:2074-2076.
42. Kuwahara T., Yamashita A., Hirakawa H., Nakayama H., Toh H., Okada N., Kuhara S., Hattori M., Hayashi T., Ohnishi Y. Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc. Nat. Acad. Sci. U.S.A. 2004, 101:14919-14924.
43. Jumas-Bilak E., Carlier J.P., Jean-Pierre H., Teyssier C., Gay B., Campos J., Marchandin H. Veillonella montpellierensis sp nov., a novel, anaerobic, gram-negative coccus isolated from human clinical samples. Int. J. Sys. Evol. Microbiol. 2004, 54:1311-1316.
44. Waldrip H.M., Martin S.A. Effects of an Aspergillus oryzae fermentation extract and other factors on lactate utilization by the ruminal bacterium Megasphaera elsdenii. J. Anim. Sci. 1993, 71:2770-2776.
45. Russell J.B., Baldwin R.L. Substrate preferences in rumen bacteria: evidence of catabolite regulatory mechanisms. Appl. Environ. Microbiol. 1978, 36:319-329.
46. Mobak L., Thomsen L.E., Jensen T.K., Knudsen K.E.B., Boye M. Increased amount of Bifidobacterium thermacidophilum and Megasphaera elsdenii in the colonic microbiota of pigs fed a swine dysentery preventive diet containing chicory roots and sweet lupine. J. Appl. Microbiol. 2007, 103:1853-1867.
47. Lawson P.A., Song Y.L., Liu C.X., Molitoris D.R., Vaisanen M.L., Collins M.D., Finegold S.M. Anaerotruncus colihominis gen. nov., sp nov., from human faeces. Int. J. Syst. Evol. Microbiol. 2004, 54:413-417.
48. Duncan S.H., Hold G.L., Harmsen H.J.M., Stewart C.S., Flint H.J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 2002, 52:2141-2146.
49. Konstantinov S.R., Awati A., Smidt H., Williams B.A., Akkermans A.D.L., de Vos W.A. Specific response of a novel and abundant Lactobacillus amylovorus-like phylotype to dietary prebiotics in the guts of weaning piglets. Appl. Environ. Microbiol. 2004, 70:3821-3830.
50. Roselli M., Finamore A., Britti M.S., Konstantinov S.R., Smidt H., de Vos W.M., Mengheri E. The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage. J. Nutr. 2007, 137:2709-2716.
51. Konstantinov S.R., Smidt H., Akkermans A.D.L., Casini L., Trevisi P., Mazzoni M., De Filippi S., Bosi P., de Vos W.M. Feeding of Lactobacillus sobrius reduces Escherichia coli F4 levels in the gut and promotes growth of infected piglets. FEMS Microbiol. Ecol. 2008, 66:599-607.